Derived from scRNA-seq, SLC26A3 is a potential therapeutic target to improve the efficacy of immunotherapy, as well as a potential diagnostic indicator to reduce post-surgical upstaging, for cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback